William D. Carlson
Corporate Officer/Principal presso Harvard Medical School
Posizioni attive di William D. Carlson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| Harvard Medical School | Corporate Officer/Principal | - | - |
Storia della carriera di William D. Carlson
Precedenti posizioni note di William D. Carlson
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ARQULE, INC. | Fondatore | - | - |
| Smith Kline & French BV | Corporate Officer/Principal | - | - |
Thrasos Therapeutics, Inc.
 Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Direttore/Membro del Consiglio | 01/01/2003 | 09/05/2013 |
| Fondatore | 01/01/2003 | - |
Formazione di William D. Carlson
| Yale University | Doctorate Degree |
| Harvard College | Undergraduate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 5 |
| Canada | 2 |
| Paesi Bassi | 2 |
Posizioni
| Corporate Officer/Principal | 2 |
| Founder | 2 |
| Director/Board Member | 1 |
Settori
| Consumer Services | 4 |
| Health Technology | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 3 |
|---|---|
Thrasos Therapeutics, Inc.
Thrasos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Thrasos Therapeutics, Inc. operates as a clinical-stage biotherapeutics company which focuses on bringing new solutions to kidney disease patients. It develops novel approaches to protect, treat and restore kidney function for this underserved patient group. The firms products include THR-184 to prevent AKI associated with cardiac surgery, THR-204 to treat certain forms of CKD, and the THR-800 series to treat cast nephropathy, a form of AKI associated with multiple myeloma. The company was founded by William D. Carlson and Murty Bosukonda in 2003 and is headquartered in Montreal, Canada. | Health Technology |
ArQule, Inc.
 ArQule, Inc. Pharmaceuticals: MajorHealth Technology ArQule, Inc. is a biopharmaceutical company, which engages in the research and development of therapeutics to treat cancers and rare diseases. The company was founded in 1993 and is headquartered in Burlington, MA. | Health Technology |
| Smith Kline & French BV |
- Borsa valori
- Insiders
- William D. Carlson
- Esperienza
